1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gestational Diabetes Treatment Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Insulin
1.2.3 SGLT-2 Inhibitors
1.2.4 Alpha-glucosidase Inhibitors
1.2.5 Others
1.3 Market by Application
1.3.1 Global Gestational Diabetes Treatment Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Gestational Diabetes Treatment Market Perspective (2017-2028)
2.2 Gestational Diabetes Treatment Growth Trends by Region
2.2.1 Gestational Diabetes Treatment Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Gestational Diabetes Treatment Historic Market Size by Region (2017-2022)
2.2.3 Gestational Diabetes Treatment Forecasted Market Size by Region (2023-2028)
2.3 Gestational Diabetes Treatment Market Dynamics
2.3.1 Gestational Diabetes Treatment Industry Trends
2.3.2 Gestational Diabetes Treatment Market Drivers
2.3.3 Gestational Diabetes Treatment Market Challenges
2.3.4 Gestational Diabetes Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Gestational Diabetes Treatment Players by Revenue
3.1.1 Global Top Gestational Diabetes Treatment Players by Revenue (2017-2022)
3.1.2 Global Gestational Diabetes Treatment Revenue Market Share by Players (2017-2022)
3.2 Global Gestational Diabetes Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Gestational Diabetes Treatment Revenue
3.4 Global Gestational Diabetes Treatment Market Concentration Ratio
3.4.1 Global Gestational Diabetes Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gestational Diabetes Treatment Revenue in 2021
3.5 Gestational Diabetes Treatment Key Players Head office and Area Served
3.6 Key Players Gestational Diabetes Treatment Product Solution and Service
3.7 Date of Enter into Gestational Diabetes Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Gestational Diabetes Treatment Breakdown Data by Type
4.1 Global Gestational Diabetes Treatment Historic Market Size by Type (2017-2022)
4.2 Global Gestational Diabetes Treatment Forecasted Market Size by Type (2023-2028)
5 Gestational Diabetes Treatment Breakdown Data by Application
5.1 Global Gestational Diabetes Treatment Historic Market Size by Application (2017-2022)
5.2 Global Gestational Diabetes Treatment Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Gestational Diabetes Treatment Market Size (2017-2028)
6.2 North America Gestational Diabetes Treatment Market Size by Type
6.2.1 North America Gestational Diabetes Treatment Market Size by Type (2017-2022)
6.2.2 North America Gestational Diabetes Treatment Market Size by Type (2023-2028)
6.2.3 North America Gestational Diabetes Treatment Market Share by Type (2017-2028)
6.3 North America Gestational Diabetes Treatment Market Size by Application
6.3.1 North America Gestational Diabetes Treatment Market Size by Application (2017-2022)
6.3.2 North America Gestational Diabetes Treatment Market Size by Application (2023-2028)
6.3.3 North America Gestational Diabetes Treatment Market Share by Application (2017-2028)
6.4 North America Gestational Diabetes Treatment Market Size by Country
6.4.1 North America Gestational Diabetes Treatment Market Size by Country (2017-2022)
6.4.2 North America Gestational Diabetes Treatment Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Gestational Diabetes Treatment Market Size (2017-2028)
7.2 Europe Gestational Diabetes Treatment Market Size by Type
7.2.1 Europe Gestational Diabetes Treatment Market Size by Type (2017-2022)
7.2.2 Europe Gestational Diabetes Treatment Market Size by Type (2023-2028)
7.2.3 Europe Gestational Diabetes Treatment Market Share by Type (2017-2028)
7.3 Europe Gestational Diabetes Treatment Market Size by Application
7.3.1 Europe Gestational Diabetes Treatment Market Size by Application (2017-2022)
7.3.2 Europe Gestational Diabetes Treatment Market Size by Application (2023-2028)
7.3.3 Europe Gestational Diabetes Treatment Market Share by Application (2017-2028)
7.4 Europe Gestational Diabetes Treatment Market Size by Country
7.4.1 Europe Gestational Diabetes Treatment Market Size by Country (2017-2022)
7.4.2 Europe Gestational Diabetes Treatment Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Gestational Diabetes Treatment Market Size (2017-2028)
8.2 Asia-Pacific Gestational Diabetes Treatment Market Size by Type
8.2.1 Asia-Pacific Gestational Diabetes Treatment Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Gestational Diabetes Treatment Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Gestational Diabetes Treatment Market Share by Type (2017-2028)
8.3 Asia-Pacific Gestational Diabetes Treatment Market Size by Application
8.3.1 Asia-Pacific Gestational Diabetes Treatment Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Gestational Diabetes Treatment Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Gestational Diabetes Treatment Market Share by Application (2017-2028)
8.4 Asia-Pacific Gestational Diabetes Treatment Market Size by Region
8.4.1 Asia-Pacific Gestational Diabetes Treatment Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Gestational Diabetes Treatment Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Gestational Diabetes Treatment Market Size (2017-2028)
9.2 Latin America Gestational Diabetes Treatment Market Size by Type
9.2.1 Latin America Gestational Diabetes Treatment Market Size by Type (2017-2022)
9.2.2 Latin America Gestational Diabetes Treatment Market Size by Type (2023-2028)
9.2.3 Latin America Gestational Diabetes Treatment Market Share by Type (2017-2028)
9.3 Latin America Gestational Diabetes Treatment Market Size by Application
9.3.1 Latin America Gestational Diabetes Treatment Market Size by Application (2017-2022)
9.3.2 Latin America Gestational Diabetes Treatment Market Size by Application (2023-2028)
9.3.3 Latin America Gestational Diabetes Treatment Market Share by Application (2017-2028)
9.4 Latin America Gestational Diabetes Treatment Market Size by Country
9.4.1 Latin America Gestational Diabetes Treatment Market Size by Country (2017-2022)
9.4.2 Latin America Gestational Diabetes Treatment Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Gestational Diabetes Treatment Market Size (2017-2028)
10.2 Middle East & Africa Gestational Diabetes Treatment Market Size by Type
10.2.1 Middle East & Africa Gestational Diabetes Treatment Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Gestational Diabetes Treatment Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Gestational Diabetes Treatment Market Share by Type (2017-2028)
10.3 Middle East & Africa Gestational Diabetes Treatment Market Size by Application
10.3.1 Middle East & Africa Gestational Diabetes Treatment Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Gestational Diabetes Treatment Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Gestational Diabetes Treatment Market Share by Application (2017-2028)
10.4 Middle East & Africa Gestational Diabetes Treatment Market Size by Country
10.4.1 Middle East & Africa Gestational Diabetes Treatment Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Gestational Diabetes Treatment Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Biocon Limited
11.1.1 Biocon Limited Company Details
11.1.2 Biocon Limited Business Overview
11.1.3 Biocon Limited Gestational Diabetes Treatment Introduction
11.1.4 Biocon Limited Revenue in Gestational Diabetes Treatment Business (2017-2022)
11.1.5 Biocon Limited Recent Developments
11.2 Eli Lilly
11.2.1 Eli Lilly Company Details
11.2.2 Eli Lilly Business Overview
11.2.3 Eli Lilly Gestational Diabetes Treatment Introduction
11.2.4 Eli Lilly Revenue in Gestational Diabetes Treatment Business (2017-2022)
11.2.5 Eli Lilly Recent Developments
11.3 Novo Nordisk
11.3.1 Novo Nordisk Company Details
11.3.2 Novo Nordisk Business Overview
11.3.3 Novo Nordisk Gestational Diabetes Treatment Introduction
11.3.4 Novo Nordisk Revenue in Gestational Diabetes Treatment Business (2017-2022)
11.3.5 Novo Nordisk Recent Developments
11.4 Boehringer Ingelheim GmbH
11.4.1 Boehringer Ingelheim GmbH Company Details
11.4.2 Boehringer Ingelheim GmbH Business Overview
11.4.3 Boehringer Ingelheim GmbH Gestational Diabetes Treatment Introduction
11.4.4 Boehringer Ingelheim GmbH Revenue in Gestational Diabetes Treatment Business (2017-2022)
11.4.5 Boehringer Ingelheim GmbH Recent Developments
11.5 Sanofi S.A.
11.5.1 Sanofi S.A. Company Details
11.5.2 Sanofi S.A. Business Overview
11.5.3 Sanofi S.A. Gestational Diabetes Treatment Introduction
11.5.4 Sanofi S.A. Revenue in Gestational Diabetes Treatment Business (2017-2022)
11.5.5 Sanofi S.A. Recent Developments
11.6 Sun Pharmaceutical Industries Limited
11.6.1 Sun Pharmaceutical Industries Limited Company Details
11.6.2 Sun Pharmaceutical Industries Limited Business Overview
11.6.3 Sun Pharmaceutical Industries Limited Gestational Diabetes Treatment Introduction
11.6.4 Sun Pharmaceutical Industries Limited Revenue in Gestational Diabetes Treatment Business (2017-2022)
11.6.5 Sun Pharmaceutical Industries Limited Recent Developments
11.7 Merck
11.7.1 Merck Company Details
11.7.2 Merck Business Overview
11.7.3 Merck Gestational Diabetes Treatment Introduction
11.7.4 Merck Revenue in Gestational Diabetes Treatment Business (2017-2022)
11.7.5 Merck Recent Developments
11.8 Novartis
11.8.1 Novartis Company Details
11.8.2 Novartis Business Overview
11.8.3 Novartis Gestational Diabetes Treatment Introduction
11.8.4 Novartis Revenue in Gestational Diabetes Treatment Business (2017-2022)
11.8.5 Novartis Recent Developments
11.9 Adocia
11.9.1 Adocia Company Details
11.9.2 Adocia Business Overview
11.9.3 Adocia Gestational Diabetes Treatment Introduction
11.9.4 Adocia Revenue in Gestational Diabetes Treatment Business (2017-2022)
11.9.5 Adocia Recent Developments
11.10 Peptron
11.10.1 Peptron Company Details
11.10.2 Peptron Business Overview
11.10.3 Peptron Gestational Diabetes Treatment Introduction
11.10.4 Peptron Revenue in Gestational Diabetes Treatment Business (2017-2022)
11.10.5 Peptron Recent Developments
11.11 AstraZeneca plc
11.11.1 AstraZeneca plc Company Details
11.11.2 AstraZeneca plc Business Overview
11.11.3 AstraZeneca plc Gestational Diabetes Treatment Introduction
11.11.4 AstraZeneca plc Revenue in Gestational Diabetes Treatment Business (2017-2022)
11.11.5 AstraZeneca plc Recent Developments
11.12 Pfizer, Inc
11.12.1 Pfizer, Inc Company Details
11.12.2 Pfizer, Inc Business Overview
11.12.3 Pfizer, Inc Gestational Diabetes Treatment Introduction
11.12.4 Pfizer, Inc Revenue in Gestational Diabetes Treatment Business (2017-2022)
11.12.5 Pfizer, Inc Recent Developments
11.13 Takeda Pharmaceutical Company Ltd
11.13.1 Takeda Pharmaceutical Company Ltd Company Details
11.13.2 Takeda Pharmaceutical Company Ltd Business Overview
11.13.3 Takeda Pharmaceutical Company Ltd Gestational Diabetes Treatment Introduction
11.13.4 Takeda Pharmaceutical Company Ltd Revenue in Gestational Diabetes Treatment Business (2017-2022)
11.13.5 Takeda Pharmaceutical Company Ltd Recent Developments
11.14 Abbott
11.14.1 Abbott Company Details
11.14.2 Abbott Business Overview
11.14.3 Abbott Gestational Diabetes Treatment Introduction
11.14.4 Abbott Revenue in Gestational Diabetes Treatment Business (2017-2022)
11.14.5 Abbott Recent Developments
11.15 Antares Pharma
11.15.1 Antares Pharma Company Details
11.15.2 Antares Pharma Business Overview
11.15.3 Antares Pharma Gestational Diabetes Treatment Introduction
11.15.4 Antares Pharma Revenue in Gestational Diabetes Treatment Business (2017-2022)
11.15.5 Antares Pharma Recent Developments
11.16 INJEX Pharma AG
11.16.1 INJEX Pharma AG Company Details
11.16.2 INJEX Pharma AG Business Overview
11.16.3 INJEX Pharma AG Gestational Diabetes Treatment Introduction
11.16.4 INJEX Pharma AG Revenue in Gestational Diabetes Treatment Business (2017-2022)
11.16.5 INJEX Pharma AG Recent Developments
11.17 Daiichi Sankyo
11.17.1 Daiichi Sankyo Company Details
11.17.2 Daiichi Sankyo Business Overview
11.17.3 Daiichi Sankyo Gestational Diabetes Treatment Introduction
11.17.4 Daiichi Sankyo Revenue in Gestational Diabetes Treatment Business (2017-2022)
11.17.5 Daiichi Sankyo Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
